Company intelligence / Profile preview

Schindler Neuroscience Consulting Group

New York City, New York, United Statescontactout.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Schindler Neuroscience Consulting Group is an independent consultancy led by Dr. Rachel Schindler. The group specializes in advising pharmaceutical and biotech companies on neuroscience drug development strategies across clinical development, medical affairs, commercial strategy, business development, public policy, and patient advocacy. Dr. Schindler brings over 20 years of experience from senior roles at Pfizer and as an industry leader in Alzheimer’s disease research consortia

Therapeutic areas: PsychiatryNeurology
Industry: Consulting

Partnerships

Participates in public-private consortia and consensus groups related to neurology drug development

Beyond the preview

Go deeper on Schindler Neuroscience Consulting Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schindler Neuroscience Consulting Group.

Explore the full profile